Particle.news
Download on the App Store

PAMI Extends Free Medicines Through December 2025 and Expands List as 2026 Means‑Tested Overhaul Advances

A means‑tested redesign in 2026 aims to contain the deficit, protecting full coverage for high‑complexity care.

Overview

  • PAMI confirms continued free access to essential drugs through December 2025 and begins adding options for respiratory, autoimmune and less common conditions.
  • From 2026, the agency plans a new scheme that ties 100% coverage to socio‑economic criteria reported to include low income thresholds, no private insurance, a single property and limits on vehicles or luxury assets.
  • Full coverage will be preserved for high‑complexity treatments such as diabetes, HIV, cancer, hemophilia, hepatitis B and C, transplants and renal failure.
  • Reports differ on partial reimbursement levels, citing ranges between 40%–60% and 40%–80%, with claims processed via PAMI’s pharmacy network and digital channels.
  • PAMI cites budget pressure and detected prescription irregularities in pursuing reforms, and it will roll out home delivery of diapers with estimated annual savings near 5 billion pesos.